27 July 2007
Futura receives SEEDA grant for DermaSys® product
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for the consumer healthcare market, is pleased to announce that it has been awarded a Grant for Research & Development of £200,000 from the South East England Development Agency (SEEDA) to support the development of a pipeline product that uses the Company’s novel DermaSys® trans-dermal delivery technology.
SEEDA, the Regional Development Agency responsible for the sustainable economic development of the South East of England, awarded the grant after a thorough review of the application to develop a specific product in relation to the DermaSys® technology. The Grant for the R&D scheme is a Department of Innovation, Universities and Skills (DIUS) national programme, where grants are awarded following assessment of the potential to achieve a technological advance in a new product or process.
Jeff Alexander, SEEDA Executive Director for Global Competitiveness, said: “I wish Futura Medical every success with the development of this product using the DermaSys® technology. SEEDA’s Grant for Research & Development scheme is designed to assist this kind of innovative product development.”
James Barder, Futura Medical’s Chief Executive, said: “We are delighted to have been awarded this grant from SEEDA, which represents a further endorsement to develop both the technical and commercial qualities of our DermaSys® drug delivery technology.”
DermaSys® is the brand name for Futura’s versatile gel technology for the rapid delivery of drugs through the skin, which the Company is continuing to assess against a wide range of generic drugs suited to topical delivery.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
Anthony Clayden, Finance Director
+44 (0) 1483 685 670
james.barder@futuramedical.co.uk
www.futuramedical.co.uk
Canaccord Adams
Mark Ashurst / Tyler Broda
Tel: + 44 (0) 20 7050 6500
For any media enquiries please contact:
Buchanan Communications Limited
Mark Court
markc@buchanan.uk.com
Rebecca Dietrich
rebeccad@buchanan.uk.com
+44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
About SEEDA
The South East England Development Agency (SEEDA) is the Government funded Agency responsible for the sustainable economic development of the South East of England – the driving force of the UK’s economy. Our aim is to create a prosperous, dynamic and inspirational region by helping businesses compete more effectively, training a highly skilled workforce, supporting and enabling our communities while safeguarding our natural resources and cherishing our rich cultural heritage.